HOMEVULNERABILITIESCVE-2023-38955
HIGH

CVE-2023-38955

CWE-668Published: August 3, 2023· Updated: Jul 9, 2026

7.5
CVSS v3.1

Official Description

ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names.

NVD Source

Technical Analysis

CVE-2023-38955 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

The vulnerability requires no privileges and no user interaction, making it a prime target for automated exploitation campaigns and worm-like propagation.

A successful exploit results in complete confidentiality breach (data exposure), with a CVSS base score of 7.5.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorNetwork
Attack ComplexityLow
Privileges Req.None
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityHigh
IntegrityNone
AvailabilityNone
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Affected Vendors & Products

zkteco1 product(s)
bioaccess ivs
Source: NVD CPE · 1 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

All References (2)

Quick Facts

CVE IDCVE-2023-38955
CVSS Score7.5 / 10
SeverityHIGH
WeaknessCWE-668
CISA KEVNo
Affected1 vendor(s)
PublishedAug 3, 2023

Related CVEs (CWE-668)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2023-38955 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.